Ignite Creation Date:
2025-12-25 @ 4:56 AM
Ignite Modification Date:
2026-02-25 @ 4:48 PM
Study NCT ID:
NCT02761018
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2016-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes
Sponsor:
Mike O'Callaghan Military Hospital
Organization:
Study Overview
Official Title:
Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators will recruit DoD beneficiaries, aged 18 years or older and diagnosed as being Type II diabetic. Patients will be randomized into one of two groups. Group 1 will use a fitness tracker but will not be able to see other participants data and group 2 will use a fitness tracker and will be able to see other members daily and weekly results. Outcome measures will be assessed at baseline, 3 months and 6 months to include hemoglobin A1c, weight, body mass index, blood pressure, and number of hours and days fitness tracker is used. The goal is to see if the group randomized into an online community will have improved activity and outcome measurements compared with those who use the pedometer alone.
Detailed Description:
Male and female DoD beneficiaries ages 18 years or older who have been diagnosed with Type II diabetes, will be recruited at the Mike O'Callaghan Federal Medical Center (MOFMC).
Screening Visit:
* Obtain signed Informed Consent Document and HIPAA Authorization (research-driven).
* Record: Date of birth, phone number, age, gender, race, ethnicity, social security number, current email address, height (in inches), weight (in pounds), blood pressure, medications list including any over-the-counter and prescription weight loss medication (name, strength, dose) or supplements.
* Subjects will have the following standard of care blood test drawn which include:
* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Visit 1 (Day 1 within 1 week of Screening Visit):
* Record: Weight (in pounds), blood pressure, and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey.
* Subjects will complete the Intake Questionnaire.
* Subjects will be assigned their Fitness Tracker username and their username and password will be recorded by the Research Coordinator.
* Subjects will be given User Instructions based off of their randomization group.
* Subjects will be instructed to follow all research procedures and that failure to do so may result in the removal from the study and the return of the Fitness Tracker.
* Subjects will be randomized by the research coordinator using a random-number generator into one of two groups (research-driven):
* Group 1: will use a fitness tracker but will not be able to see other participant's data.
* Group 2: will use a fitness tracker and will be able to see other member's daily and weekly results.
* Both groups will receive the scripted feedback at set time intervals by the Research Coordinators.
* Subjects will be provided a fitness tracker and instructed on how to use it.
* If subject is a DoD beneficiary, and finishes all study-related procedures at month 6, they will keep the fitness tracker. If a subject does not complete all study-related procedures, they will be asked to return the fitness tracker so the investigators can erase their data and re-issue to another study subject.
* If subject is active duty or a DoD employee, regardless of their study completion, they will be asked to complete Temporary Issue Receipt and bring back the fitness tracker at the end of the study.
Visit 2 (Month 3/90 days post Visit 1):
* Record: Weight (in pounds), blood pressure and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey.
* Subjects will complete the Follow up Questionnaire.
* Obtain information from their fitness tracker.
* Subjects will have the following standard of care blood test drawn which include:
* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Final Visit 3 (Month 6/90 days post Visit 2):
* Record: Weight (in pounds), blood pressure and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey and be asked some additional questions.
* Subjects will complete the Follow up Questionnaire.
* Obtain information from their fitness tracker.
* Subjects will have the following standard of care blood test drawn which include:
* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Screening Visit:
* Obtain signed Informed Consent Document and HIPAA Authorization (research-driven).
* Record: Date of birth, phone number, age, gender, race, ethnicity, social security number, current email address, height (in inches), weight (in pounds), blood pressure, medications list including any over-the-counter and prescription weight loss medication (name, strength, dose) or supplements.
* Subjects will have the following standard of care blood test drawn which include:
* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Visit 1 (Day 1 within 1 week of Screening Visit):
* Record: Weight (in pounds), blood pressure, and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey.
* Subjects will complete the Intake Questionnaire.
* Subjects will be assigned their Fitness Tracker username and their username and password will be recorded by the Research Coordinator.
* Subjects will be given User Instructions based off of their randomization group.
* Subjects will be instructed to follow all research procedures and that failure to do so may result in the removal from the study and the return of the Fitness Tracker.
* Subjects will be randomized by the research coordinator using a random-number generator into one of two groups (research-driven):
* Group 1: will use a fitness tracker but will not be able to see other participant's data.
* Group 2: will use a fitness tracker and will be able to see other member's daily and weekly results.
* Both groups will receive the scripted feedback at set time intervals by the Research Coordinators.
* Subjects will be provided a fitness tracker and instructed on how to use it.
* If subject is a DoD beneficiary, and finishes all study-related procedures at month 6, they will keep the fitness tracker. If a subject does not complete all study-related procedures, they will be asked to return the fitness tracker so the investigators can erase their data and re-issue to another study subject.
* If subject is active duty or a DoD employee, regardless of their study completion, they will be asked to complete Temporary Issue Receipt and bring back the fitness tracker at the end of the study.
Visit 2 (Month 3/90 days post Visit 1):
* Record: Weight (in pounds), blood pressure and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey.
* Subjects will complete the Follow up Questionnaire.
* Obtain information from their fitness tracker.
* Subjects will have the following standard of care blood test drawn which include:
* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Final Visit 3 (Month 6/90 days post Visit 2):
* Record: Weight (in pounds), blood pressure and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey and be asked some additional questions.
* Subjects will complete the Follow up Questionnaire.
* Obtain information from their fitness tracker.
* Subjects will have the following standard of care blood test drawn which include:
* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: